Proposal of predictive model on survival in unresectable pancreatic cancer receiving systemic chemotherapy
Noriko Kawamura Ishii, Hiroki Nishikawa, Yoshinori Iwata, Hirayuki Enomoto, Hironori Tanaka, Nobuyuki Katakami, Takashi Nishimura, Hiroko Iijima, Shuhei Nishiguchi · Journal of Cancer · 2019
Not cached yet. This record was fetched live for this request and is stored after the lookup. Reopening the page should serve the cached copy.
Journal of Cancer · Ivyspring International Publisher · article · 2019
Abstract
Aims: To construct a predictive model for overall survival (OS) in unresectable pancreatic cancer (PaC) undergoing systemic chemotherapy and to confirm its accuracy in an independent cohort. Patients and methods:The training set (Ts) and the validation set (Vs) included 93 patients (median age=71 years) and 75 patients (median age=76 years).In the Ts, we examined variables linked to OS by uni-and multivariate analyses and constructed a predictive model for OS.Next, we evaluated the reproducibility of the proposed model in the Vs.
Results:In the multivariate analysis for the Ts, PaC stage IV (P=0.0020) and carbohydrate antigen (CA) 19-9 >437.5 IU/l (P=0.0237) were identified to be significant factors associated with OS.Patients with PaC stage IV or not were given a score of 1 or 0, whereas patients with CA19-9 >437.5 IU/l or <437.5 IU/l were given a score of 1 or 0. Sum of the point of PaC stage (0 or 1) and CA19-9 (0 or 1) was defined as "PaC-CA score".In the Ts, there were 16 patients with score 0, 40 with score 1 and 37 with score 2, while in the Vs, there were 9 patients with score 0, 32 with score 1 and 34 with score 2.
Overall P values reached significance in the Ts (P=0.0002), the Vs (P=0.0029) and the combined Ts and Vs (P<0.0001)among patients with PaC score 0, 1 and 2. Conclusion: PaC-CA score can be helpful for risk stratification in PaC patients undergoing systemic chemotherapy.
Open the resolved locator · 10.7150/jca.38861
Metadata licence: OpenAlex metadata (CC0)